| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
10,791 |
6,049 |
$276K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
8,809 |
4,737 |
$67K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,932 |
973 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
30 |
12 |
$883.67 |
| 84443 |
Thyroid stimulating hormone (TSH) |
161 |
100 |
$679.71 |
| 80053 |
Comprehensive metabolic panel |
210 |
121 |
$520.19 |
| 80061 |
Lipid panel |
123 |
72 |
$384.94 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
153 |
92 |
$286.38 |
| 85027 |
|
160 |
90 |
$248.19 |
| 36415 |
Collection of venous blood by venipuncture |
372 |
204 |
$217.83 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
45 |
31 |
$71.79 |
| 86592 |
|
53 |
40 |
$54.39 |
| G0471 |
Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) |
25 |
16 |
$0.00 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
28 |
12 |
$0.00 |